A viral vector model for circuit-specific synucleinopathy
Preprint
Abstract
In Parkinson’s disease (PD), pathomechanisms such as aberrant network dysfunctions can be elucidated by conducting multiscale explorations in animal models. However, the lack of specificity in the existing models limits a restricted targeting of individual network elements and characterization of PD as a “circuitopathy”. We therefore developed a cell-type specific viral vector (AAV2/9-Cre ON -A53T-αSyn) mouse model that allows to induce synucleinopathy within individual circuit elements in vivo . When specifically targeted to dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc), our approach recapitulates the main hallmarks of the disease, namely Lewy-body-like aggregation, progressive cellular and nigrostriatal projections loss, together with locomotor impairment. Our strategy is supported by new state-of-the-art analytical approaches for cell quantification and behavior characterization. Altogether, we provide a novel model of synucleinopathy, which offers new opportunities to study the contribution of individual network elements to disease pathomechanisms.Keywords
This publication has 63 references indexed in Scilit:
- A Hitchhiker's guide through the bio‐image analysis software universeFEBS Letters, 2022
- Generation of a DAT-P2A-Flpo mouse line for intersectional genetic targeting of dopamine neuron subpopulationsCell Reports, 2021
- Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and DrawbacksNeurotoxicity Research, 2021
- Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s diseaseCell and tissue research, 2018
- Cre‐loxP‐Mediated Recombination: General Principles and Experimental ConsiderationsCurrent Protocols in Mouse Biology, 2017
- Serotonin in Parkinson's diseaseBehavioural Brain Research, 2015
- Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancementMovement Disorders, 2014
- Deep Brain Stimulation for Parkinson DiseaseArchives of Neurology, 2011
- Norepinephrine: The redheaded stepchild of Parkinson's diseaseBiochemical Pharmacology, 2007
- Stages in the development of Parkinson’s disease-related pathologyCell and tissue research, 2004